Biotechnology - Licensing, Emergent BioSolutions

Filter

Popular Filters

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

20-08-2014

US biopharmaceutical firm Emergent BioSolutions and Germany’s MorphoSys have entered into an agreement…

BiotechnologyEmergent BioSolutionsES414GermanyLicensingMOR209/ES414MorphoSysOncologyProstate cancerUSA

Valneva deal with Emergent BioSolutions for development of vaccines in the EB66 cell line

11-03-2014

European biotechnology company Valneva has signed a new research license agreement and transferred an…

BiotechnologyEB66 cell lineEmergent BioSolutionsLicensingVaccinesValneva

Emergent BioSolutions gets exclusive US commercial rights to pandemic flu vaccine candidate

31-12-2012

US vaccine maker Emergent BioSolutions (NYSE: EBS) has signed a license agreement with fellow USA-based…

BiotechnologyEmergent BioSolutionsLicensingNorth AmericaVaccinesVaxInnate Corp

COMPANY SPOTLIGHT

Menarini

Back to top